Corticosterone pathway

The corticosterone pathway refers to the biochemical sequence of enzymatic reactions and signaling events involved in the synthesis and action of corticosterone, a steroid hormone produced in the adrenal cortex. In humans, corticosterone serves as an intermediate in the production of aldosterone and a minor glucocorticoid, whereas in rodents, it is the primary glucocorticoid involved in the stress response (Wikipedia, 2023). The pathway is regulated by the hypothalamic-pituitary-adrenal (HPA) axis and involves key enzymes such as 11β-hydroxylase (CYP11B1) and receptors like the glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) (StatPearls, 2023). Dysregulation of this pathway is linked to conditions such as Cushing's syndrome, Addison's disease, and metabolic disorders (Mayo Clinic, 2023). Pharmacological intervention typically targets specific enzymes to inhibit steroid synthesis or modulates receptor activity to manage inflammatory and endocrine diseases (PubChem, 2023). Key therapeutic agents include metyrapone, which inhibits CYP11B1, and mifepristone, which antagonizes the glucocorticoid receptor (NIH, 2023). Monitoring this pathway is critical in managing endocrine disorders and ensuring that pharmacological suppression does not lead to acute adrenal insufficiency (PubMed, 2022).

Other names

Glucocorticoid biosynthetic pathwayCorticosteroid synthesis pathwayAdrenal steroidogenesis pathwayCorticosterone signaling pathway

Inhibition of steroidogenic enzymes such as 11β-hydroxylase (CYP11B1) to reduce hormone production, or antagonism of glucocorticoid and mineralocorticoid receptors to block downstream signaling.